Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature
- 31 July 1985
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (1) , 119-121
- https://doi.org/10.1016/0002-9343(85)90555-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Chemotherapy of Malignant MelanomaJournal of Investigative Dermatology, 1983
- Uveal Malignant Melanoma and Levodopa Therapy in Parkinson’s DiseaseOphthalmology, 1982
- Dopamine: A Novel Antitumor Agent Active Against B-16 Melanoma In VivoJournal of Investigative Dermatology, 1978
- L-Dopa methyl ester as a new antitumour agentNature, 1977
- L-Dopa: Selective Toxicity for Melanoma Cells in VitroScience, 1977
- Levodopa and melanomaNeurology, 1974
- Evaluation of safety and efficacy of levodopa in Parkinson's disease and syndromeNeurology, 1972
- Ceinical characteristics of the genetic variety of cutaneous melanoma in manCancer, 1971
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- 3,4-DIHYDROXYPHENYLALANINE (DOPA) EXCRETION IN PATIENTS WITH MALIGNANT MELANOMAThe Lancet, 1962